Baseline clinical measures and early response predict success in verteporfin photodynamic therapy for neovascular age-related macular degeneration.

García-Fiñana, M; Murjaneh, S; Mahmood, S; Harding, S P

García-Fiñana, M; Murjaneh, S; Mahmood, S; Harding, S P.

Affiliation

García-Fiñana M; Centre for Medical Statistics and Health Evaluation, Faculty of Health and Life Sciences, University of Liverpool, and St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.

Eye (Lond) ; 24(7): 1213-9, 2010 Jul.

Article in En | MEDLINE | ID: mdl-20075972

Subject(s)

Macular Degeneration/drug therapy; Photochemotherapy/methods; Photosensitizing Agents/therapeutic use; Porphyrins/therapeutic use; Visual Acuity/physiology; Age Factors; Aged; Aged, 80 and over; Contrast Sensitivity; Female; Humans; Logistic Models; Longitudinal Studies; Macular Degeneration/physiopathology; Male; Middle Aged; Prospective Studies; United Kingdom; Verteporfin

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Photochemotherapy / Porphyrins / Visual Acuity / Photosensitizing Agents / Macular Degeneration Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eye (Lond) Journal subject: OFTALMOLOGIA Year: 2010 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google